Jennison Associates LLC Has $45.10 Million Stock Holdings in Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Jennison Associates LLC trimmed its position in Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 16.0% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,329,095 shares of the biopharmaceutical company’s stock after selling 252,995 shares during the quarter. Jennison […]
More Stories
USDA Employee Among 6 Charged in One of the Largest Food Stamp Fraud Cases in US History
By Chase Smith A longtime U.S. Department of Agriculture employee and five others have been charged in a sprawling fraud...
Oreo Maker Mondelez Sues Aldi Over Alleged Trademark Infringement
By Chase Smith Mondelez International has filed a federal lawsuit against Aldi, accusing the supermarket chain of infringing on the...
New COVID Variant NB.1.8.1 Starting to Spread Worldwide: What We Know
By Jack Phillips The World Health Organization (WHO) has said that the COVID-19 variant NB.1.8.1 is causing more infections worldwide,...
Trump’s Tariffs Deliver Record $23 Billion Revenue in May
By Andrew Moran U.S. tariff revenues reached an all-time high in May as President Donald Trump’s trade policies started to...
How to Get Bot Lobbies in Fortnite? (2025 Guide)
Skills, strategies, and reflexes are important parts of the game. Still, some people would just break from all competition and...
NVIDIA Co. (NASDAQ:NVDA) Shares Sold by Point72 Italy S.r.l.
Point72 Italy S.r.l. reduced its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 66.7% during the 4th quarter, according...